Tech Nation + BioTech Nation + Global BioEntrepreneurship
Episode 26-45
Air Date: November 11, 2026
On this week’s Tech Nation, Moira speaks with Dr. Tim Schnabel, Founder & CEO of Switch Bioworks, about a step forward in biotech that could revolutionize the global fertilizer industry, and impact the way food is grown around the world. Then, Dr. Ijeoma Uchegbu, President of Wolfson College at the University of Cambridge, joins to talk about her book, “Chain Reaction: How Chemistry Shapes Us and Our World”.
Episode 26-44
Air Date: November 4, 2026
On this week’s Tech Nation, Moira speaks with Stanford On this week’s Tech Nation, we look back at a 2005 interview with Theranos founder Elizabeth Holmes. Now, as the former CEO serves prison time for fraud, what can her earliest on-record interview tell us about where things went wrong? Then, do you have a narcissist in your life? Dr. Ramani Durvasula joins to tell us how to recognize them, and keep them from bringing you down.
Episode 26-43Air Date: October 29, 2026
On this week’s Tech Nation, Frontline Stories from Ukraine’s International Legion with Military Historian Dr. Shannon Monaghan. Then, for Type I diabetics, the New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs, and Daniel Kraft reviews the BioTech Nation session from NextMed Health 2025.
BioTech Nation
PODCASTS
November 10, 2026
Dr. Tim Schnabel,
Founder & CEO,
Switch Bioworks
- On this episode of Biotech Nation, Dr. Tim Schnabel talks about how Switch Bioworks aims to revolutionize the fertilizer industry by engineering special microbes in place of chemical fertilizers. With a biotech approach, they hope to reduce the cost and environmental impact of industrial fertilizers, and they're already working with the USDA and EPA on trials.
November 3, 2026
Founder & Former CEO, Theranos
On this episode of BioTech Nation, we look back at the first on-record interview with Theranos founder Elizabeth Holmes, recorded at KQED studios in 2005. At the time of the interview, Holmes was just 21 years old, and her company had already received almost $6 million in funding from investors. Now, over two decades have passed, and Elizabeth Holmes is serving time in prison for fraud. Revisiting the interview today, what can it tell us about where things went wrong?
The J.P. Morgan
Healthcare Conference 2026
5 Companies Ready to
Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma